Simulations Plus Inc SLP
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Simulations Plus to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
-
Simulations Plus Optimizes Business Unit Structure to Support Future Growth Following Recent Strategic Acquisitions
-
Simulations Plus Releases DILIsym® X
-
Simulations Plus Releases ADMET Predictor® Version 12
-
Simulations Plus to Participate in KeyBanc’s 25th Annual Technology Leadership Forum
-
Simulations Plus Announces New Research Project with the International Collaboration on Cosmetics Safety
Trading Information
- Previous Close Price
- $30.24
- Day Range
- $30.19–30.81
- 52-Week Range
- $29.95–51.22
- Bid/Ask
- $29.00 / $31.25
- Market Cap
- $604.63 Mil
- Volume/Avg
- 76,744 / 158,209
Key Statistics
- Price/Earnings (Normalized)
- 32.92
- Price/Sales
- 9.17
- Dividend Yield (Trailing)
- 0.79%
- Dividend Yield (Forward)
- 0.79%
- Total Yield
- 0.79%
Company Profile
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. It generates maximum revenue from the software segment.
- Sector
- Healthcare
- Industry
- Health Information Services
- Stock Style Box
- Small Growth
- Total Number of Employees
- 197
- Website
- https://www.simulations-plus.com
Comparables
Valuation
|
Metric
|
SLP
|
002093
|
688695
|
|---|---|---|---|
Price/Earnings (Normalized) | 32.92 | 68.16 | 27.58 |
Price/Book Value | 3.34 | 2.00 | 3.67 |
Price/Sales | 9.17 | 12.92 | 11.46 |
Price/Cash Flow | 34.99 | 41.40 | 25.20 |
Price/Earnings
SLP
002093
688695
Financial Strength
|
Metric
|
SLP
|
002093
|
688695
|
|---|---|---|---|
Quick Ratio | 11.41 | 2.23 | 28.70 |
Current Ratio | 11.98 | 5.85 | 28.87 |
Interest Coverage | — | 22.41 | 97.54 |
Quick Ratio
SLP
002093
688695
Profitability
|
Metric
|
SLP
|
002093
|
688695
|
|---|---|---|---|
Return on Assets (Normalized) | 8.02% | 2.45% | 14.43% |
Return on Equity (Normalized) | 8.65% | 2.90% | 15.59% |
Return on Invested Capital (Normalized) | 6.03% | 2.98% | 15.22% |
Return on Assets
SLP
002093
688695
Health Information Services Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| GE HealthCare Technologies Inc Common Stock
GEHC
| Gqxhwztn | Rvzx | $41.7 Bil | |||
| Veeva Systems Inc Class A
VEEV
| Kbbqyklzw | Ccbgg | $33.1 Bil | |||
| Pro Medicus Ltd
PMCUF
| — | Ypdvsvg | $12.8 Bil | |||
| Solventum Corp
SOLV
| — | Xrmhwz | $11.7 Bil | |||
| Tempus AI Inc Class A common stock
TEM
| — | Mzv | $8.2 Bil | |||
| Doximity Inc Class A
DOCS
| — | Htvmln | $8.1 Bil | |||
| M3 Inc
MTHRF
| — | Pgjjqrk | $7.8 Bil | |||
| M3 Inc ADR
MTHRY
| — | Nlfjt | $7.8 Bil | |||
| HealthEquity Inc
HQY
| — | Jvpmld | $7.3 Bil | |||
| R1 RCM Inc
RCM
| — | Qpld | $6.0 Bil |
United States